Stocks Comparison
Enovis vs Edwards Lifesciences: revenue, profit, margins and growth compared
Enovis brought in $2.2B of revenue in fiscal 2025, Edwards Lifesciences $6.1B in fiscal 2025. Revenue changed by +6.7% at Enovis and +11.5% at Edwards Lifesciences on the year before, so Edwards Lifesciences grew faster. Enovis kept -52.7% of its revenue as net profit, Edwards Lifesciences 17.7%. Free cash flow was $19.9M at Enovis and $1.3B at Edwards Lifesciences.
Side by side, latest fiscal year
| ENOV | EW | |
|---|---|---|
| Fiscal year ended | FY2025 (December 31, 2025) | FY2025 (December 31, 2025) |
| Revenue | $2.2B | $6.1B |
| Revenue growth | +6.7% | +11.5% |
| Net income | -$1.2B | $1.1B |
| Net margin | -52.7% | 17.7% |
| Free cash flow | $19.9M | $1.3B |
| Free cash flow margin | 0.9% | 22.0% |
| Earnings per share (diluted) | -$20.75 | $1.83 |
| Cash | $36.4M | $2.9B |
| Debt | $1.3B | $598.3M |
| Price to earnings | n/a | 47.1 |
| Market value | $1.1B | $49.7B |
| Dividend yield | n/a | n/a |
| Rank by revenue in sector | #102 of 523 · Health care | #54 of 523 · Health care |
Over the years
Questions about Enovis and Edwards Lifesciences
Which is bigger by revenue, Enovis or Edwards Lifesciences?
Edwards Lifesciences is bigger by revenue: $6.1B in fiscal 2025, against $2.2B for Enovis in fiscal 2025.
Which keeps more of its revenue as profit, Enovis or Edwards Lifesciences?
Enovis had a net margin of -52.7% in fiscal 2025; Edwards Lifesciences had 17.7% in fiscal 2025.
Which grew revenue faster, Enovis or Edwards Lifesciences?
In their latest fiscal years revenue changed by +6.7% at Enovis and +11.5% at Edwards Lifesciences.
Where do these numbers come from?
From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.